Visgo Therapeutics

About:

Visgo Therapeutics develops products to treat joint diseases.

Description:

Visgo is developing best in class products to treat joint diseases, such as osteoarthritis. Using a proprietary delivery platform, these products will be locally delivered for release over time within the joint with minimal systemic exposure. Our first product, VG201, delivers an NSAID by sustained release for the treatment of knee osteoarthritis pain, and is now in preclinical testing.

Total Funding Amount:

$725000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Burlington, Massachusetts, United States

Founded Date:

2013-01-01

Contact Email:

jbertonis(AT)visgotx.com

Founders:

Jeanne Bertonis

Number of Employees:

1-10

Last Funding Date:

2015-03-09

IPO Status:

Private

Industries: